SureTrader SureTrader
Home > Boards > US Listed > Medical - Equipment >

West Pharmaceutical (WST)

WST RSS Feed
Add WST Price Alert      Hide Sticky   Hide Intro
Moderator: braden
Search This Board:
Last Post: 9/15/2016 4:57:31 PM - Followers: 2 - Board type: Free - Posts Today: 0

http://www.westpharma.com/en/Pages/Default.aspx
http://www.westpharma.com/en/about/Pages/GlobalFacilities.aspx
http://www.pharmaasia.com/2015/04/eric-green-is-new-ceo-at-west-pharma/

-----PLEASE NOTE--------

THIS IS NOT A DAY TRADE STOCK

THIS STOCK HAS AVERAGED 28% PER YEAR FOR 10 YEARS STRAIGHT

2013   2 for 1 stock split

2004   2 for 1 stock split

West Pharmaceutical Services, Inc. manufactures components and systems for injectable drug delivery and plastic packaging, and delivery system components for the healthcare, personal care, and consumer products markets. The company operates in two segments, Pharmaceutical Systems and Tech Group. The Pharmaceutical Systems segment engages in the design, manufacture, and sale of various elastomer, metal, and plastic components used in parenteral drug delivery for the pharmaceutical, generic, and biopharmaceutical industries. It offers various pharmaceutical packaging components, such as stoppers and discs, plungers, seals, dropper bulbs, needle shields and tip caps, and sterile devices. This segment also provides contract analytical laboratory services for testing and evaluating primary drug packaging components. The Tech Group segment produces injection molded components and devices, such as contact lens storage kits, pill dispensers, and disposable blood collection systems for surgical, ophthalmic, diagnostic, and drug delivery systems. This segment also involves in the manufacture and assembly of systems and devices used for nasal, oral, pulmonary, and injectable delivery of drugs used to treat diseases. The company's customers include pharmaceutical, biotechnology, generic drug, and medical-device producers. West Pharmaceutical sells its products primarily in the United States,Asia,Germany,France,and other European countries. It markets its products and services principally through its own sales force and distribution network, as well as through sales agents and distributors. The company was founded in 1923 and is headquartered in Lionville, Pennsylvania.

West Pharmaceutical Services Inc.'s Corporate Governance Quotient (CGQ®) as of 1-Apr-08 is better than 97.2% of S&P 600 companies and 97.9% of Health Care Equipment & Services companies.
Improving Global Healthcare
West helps improve the safe delivery of pharmaceutical, health care and personal care products. Media Relations Contact for North and South America

Second Quarter 2016 Highlights

  • Reported net sales of $388.0 million grew 7.9% over the prior-year quarter.  Net sales at constant currency grew by 8.2%.
    Second quarter 2016 reported diluted EPS was $0.60 as compared to $0.38 in the prior-year quarter.  Excluding restructuring and retirement charges from both periods, adjusted diluted EPS was $0.59, a growth of 26% over the prior-year quarter.
    Raising full-year 2016 net sales and the lower-end of adjusted diluted EPS guidance range.
    • Full-year net sales are now expected to be between $1.505 billion and $1.520 billion compared to prior range of $1.49 billion to $1.51 billion.
      Full-year 2016 adjusted diluted EPS is now expected to be between $2.15 and $2.25 compared to a prior range of $2.12 to $2.25.

"Adjusted diluted EPS" and "net sales at constant currency" are Non-GAAP measurements.  See discussion under the heading "Non-GAAP Financial Measures" in this release. 

Executive Commentary

"We had a successful quarter with solid organic sales growth, increased gross and operating profit margins and new product launches and approvals," said Eric M. Green, President and Chief Executive Officer.  "Led by our Commercial group, both the Proprietary Products and Contact-Manufactured Products segments contributed to overall organic sales growth, with broad-based growth in all three market units of Biologics, Generics and Pharma.  We continue to see double-digit sales growth in our high-value product offerings including Westar RS® and Westar RU®, Daikyo®, FluroTec® and NovaPure® components."

"We had another strong quarter of gross margin expansion fueled by high-single digit organic sales growth, favorable product mix and operational efficiencies.  I am pleased that our Global Operations initiatives are successfully increasing throughput and reducing lead times.  As a result, we saw a sequential quarterly reduction in backlog levels and remain on track with our target of achieving faster lead times in the second half of the year and reducing backlog levels that better match underlying demand."

"Earlier this month, the U.S. Food and Drug Administration (FDA) approved the first combination product that incorporates an injectable drug with West's SmartDose® technology for use in the United States.  This milestone exemplifies West's strategy of providing the highest quality components and systems to meet our customers' needs for injectable drug delivery solutions; in this case, an integrated containment system that combines the novel SmartDose device with a Daikyo Crystal Zenith® container and a Flurotec® piston.  I am proud of the work of our Innovation and Technology team and partners to achieve this milestone.  The many years of work and dedication to this project have paved the way for new opportunities for the on-body delivery of injectable drugs."

Mr. Green concluded, "Since the launch of our market-led strategy and business realignment at the start of the year, our teams have performed well, and the company is well positioned for future success.  We continue to see solid end-market demand in our Proprietary Products segment and expect to see higher organic sales growth in our Contract-Manufactured Products segment in the second half of the year.  With these trends, we are raising our full-year 2016 organic sales growth guidance to a new range of between 7% and 9% and are raising the lower-end of our adjusted diluted EPS guidance

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
WST
Current Price
Volume:
Bid Ask Day's Range
SureTrader
WST News: Current Report Filing (8-k) 09/26/2016 04:56:45 PM
WST News: West Appoints David A. Montecalvo Senior Vice President, Global Operations and Supply Chain 09/26/2016 08:00:00 AM
WST News: Confidential Treatment Order (ct Order) 09/15/2016 04:01:31 PM
WST News: Statement of Changes in Beneficial Ownership (4) 09/13/2016 09:22:00 AM
WST News: Initial Statement of Beneficial Ownership (3) 09/13/2016 08:24:24 AM
News News Alert: Current Report Filing (8-k) 09/26/2016 04:56:45 PM
PostSubject
#84   I live 7 miles from the Clearwater plant braden 09/15/16 04:57:31 PM
#83   Still low :-) Brother still working for wst, good future wagner 09/15/16 02:44:09 PM
#82   This is the twenty-fourth consecutive annual increase in braden 09/14/16 07:35:15 PM
#81   WST INCREASES DIVIDEND BY 8% braden 09/14/16 07:30:35 PM
#80   http://www.nytimes.com/2016/09/03/us/politics/hillary-clinton-epipen-mylan.html? braden 09/07/16 06:11:56 PM
#79   http://www.westpharma.com/en/videos/Pages/TechGroup.aspx braden 08/25/16 04:15:20 PM
#78   https://www.youtube.com/watch?v=_qaSsQ02-kU braden 08/22/16 04:19:18 PM
#77   braden 08/14/16 05:01:32 PM
#76   WST up over 30% per year for last braden 08/10/16 04:34:03 PM
#75   Typical WST action.... Market down two days in braden 08/10/16 04:32:49 PM
#74   West Pharmaceutical Services Inc. (WST) Sets New 12-Month braden 08/06/16 03:11:32 PM
#73   West Pharmaceutical Services Inc. (NYSE:WST) was upgraded by braden 08/05/16 03:45:51 PM
#72   http://baseballnewssource.com/markets/west-pharmaceutical-services-inc-wst-upgra braden 08/05/16 03:45:11 PM
#71   http://www.westpharma.com/en/about/Pages/GlobalFacilities.aspx braden 07/31/16 08:54:58 AM
#70   another split coming?? braden 07/29/16 07:18:18 PM
#69   This has turned out to be BIG for west... braden 07/28/16 07:00:42 PM
#68   West also increases year end outlook. braden 07/28/16 02:38:18 PM
#67   West now up over 2.5% percent for the braden 07/28/16 02:37:45 PM
#66   West teams up with Amgen braden 07/28/16 02:36:21 PM
#65   West beats by 4 cents braden 07/28/16 02:33:28 PM
#64   $WST DD Notes ~ http://www.ddnotesmaker.com/WST stocktrademan 10/28/14 10:10:08 AM
#63   ~ Thursday! $WST ~ Earnings posted, pending or Penny Roger$ 02/14/12 01:58:39 AM
#62   West Breaks Ground for its Second Manufacturing Plant braden 06/15/11 04:02:34 PM
#61   West to Present at Jefferies Conference braden 05/31/11 06:18:38 PM
#60   West Announces Third Quarter 2011 Dividend braden 05/06/11 06:23:46 PM
#59   West Announces First Quarter 2011 Results braden 04/28/11 04:23:33 PM
#58   WST is just amazing...My largest holding too !!! braden 04/27/11 05:38:55 AM
#57   West to Host 2011 First Quarter Conference Call braden 04/22/11 06:12:23 AM
#56   Sold this am at $45.62 braden 04/08/11 07:12:12 PM
#55   West to Present at Barclays Capital Conference braden 03/10/11 05:37:35 PM
#54   The Board also approved payment of the second-quarter braden 02/26/11 12:02:09 PM
#53   http://www.westpharma.com/en/Investors/Pages/NewsReleases.aspx?reqtype=releasetx braden 02/26/11 12:00:47 PM
#52   UP big today...Earnings tomorrow!!!! braden 02/16/11 03:52:41 PM
#51   West to Present at UBS Investor Conference braden 02/03/11 02:43:57 AM
#50   Dividend info.Nice trend every quarter braden 01/09/11 04:37:11 PM
#49   This is my largest holding.Plan to retire off braden 01/09/11 04:34:20 PM
#48   Pre drop was above $50 pps braden 01/07/11 04:19:31 PM
#47   Huge world wide company with crazy low o/s braden 01/07/11 04:18:50 PM
#46   This one has been easy.Up and down chart. braden 01/07/11 04:18:08 PM
#45   $42 bucks time to sell braden 12/31/10 05:14:18 PM
#44   33.65 TIME TO BUY!!!!!! braden 09/10/10 08:19:48 PM
#43   West to Present at Jefferies Investor Conference braden 06/02/10 08:32:54 PM
#42   West Pharmaceutical Services, Inc. (NYSE: WST) today announced braden 05/07/10 05:35:12 PM
#41   West to Host Analyst and Investor Day braden 04/27/10 05:28:55 AM
#40   West Pharmaceutical Services, Inc. (NYSE:WST) today announced that braden 02/22/10 08:40:15 PM
#39   West Announces Fourth Quarter, Full Year 2009 Results braden 02/18/10 08:22:25 PM
#38   Investors braden 11/23/09 08:37:30 PM
#37   West to Present at Investor Conference braden 11/12/09 06:48:29 PM
#36   The Company announced plans to restructure certain business braden 11/06/09 07:42:22 PM
#35   West to Host 2009 Third Quarter Conference Call braden 10/27/09 04:05:29 PM
PostSubject